Abstract
Our data underline the efficacy of active adjuvant treatment for GBM in overall survival, optimally with RTCT with Stupp protocol, even in an elderly and ECOG> 1 group, without grade III-IV toxicities. As expected, baseline ECOG (before starting local treatment), age and multifocal tumor are the most important prognosis predictor.
| Original language | English |
|---|---|
| Pages (from-to) | S858-S860 |
| Journal | Radiotherapy and Oncology |
| Volume | 161 |
| Issue number | Supplement 1 |
| DOIs | |
| Publication status | Published - 01 Aug 2021 |